Decera Clinical Education
@deceraclinicaledu.bsky.social
We're becoming Decera Clinical Education! A leader in the development of innovative & interactive #CME/#CE educational programs for healthcare professionals | Clinically relevant, evidence-based. #MedSky #MedicalEducation 👉 https://bit.ly/3XD4G1Z
Pinned
We’re now Decera Clinical Education (deh-SAIR-uh), formerly CCO. Our name has evolved, but our expert-led CME/CE and trusted medical education remain the same. Thank you for celebrating this next chapter with us! Learn more:
Learn more → deceraclinical.com/education/co...
Learn more → deceraclinical.com/education/co...
🍃 Featured Faculty Spotlight: Kristin N. Maher, MD, PhD! Join us at our Friday Satellite Symposium before #ASH2025 for evidence-based strategies shaping the future of non-factor replacement therapy.
👉 Learn more: https://bit.ly/48oyKn3
#HematologyEducation #CME #MedicalEducation
👉 Learn more: https://bit.ly/48oyKn3
#HematologyEducation #CME #MedicalEducation
November 30, 2025 at 6:24 PM
🍃 Featured Faculty Spotlight: Kristin N. Maher, MD, PhD! Join us at our Friday Satellite Symposium before #ASH2025 for evidence-based strategies shaping the future of non-factor replacement therapy.
👉 Learn more: https://bit.ly/48oyKn3
#HematologyEducation #CME #MedicalEducation
👉 Learn more: https://bit.ly/48oyKn3
#HematologyEducation #CME #MedicalEducation
How do we advance migraine care? Together. 🤝 Watch our on demand video, earn #CME: https://bit.ly/48BvrtZ
November 28, 2025 at 9:10 PM
How do we advance migraine care? Together. 🤝 Watch our on demand video, earn #CME: https://bit.ly/48BvrtZ
Experience our new look in person at #ASH25 👀✨
Decera Clinical Education (formerly CCO) is making its debut!
Visit us at Booth 142.
Explore Decera Clinical Education: https://bit.ly/3XD4G1Z
#ASH2025 #HematologyEducation #MedicalEducation #DeceraClinical
Decera Clinical Education (formerly CCO) is making its debut!
Visit us at Booth 142.
Explore Decera Clinical Education: https://bit.ly/3XD4G1Z
#ASH2025 #HematologyEducation #MedicalEducation #DeceraClinical
November 26, 2025 at 8:53 PM
Experience our new look in person at #ASH25 👀✨
Decera Clinical Education (formerly CCO) is making its debut!
Visit us at Booth 142.
Explore Decera Clinical Education: https://bit.ly/3XD4G1Z
#ASH2025 #HematologyEducation #MedicalEducation #DeceraClinical
Decera Clinical Education (formerly CCO) is making its debut!
Visit us at Booth 142.
Explore Decera Clinical Education: https://bit.ly/3XD4G1Z
#ASH2025 #HematologyEducation #MedicalEducation #DeceraClinical
🔥 Spotlight: Dr. Michael D. Jain
A leader in CAR T–cell therapy ahead of #ASH2025.
Join our Hematology Symposia, register in-person or online: https://bit.ly/4nyUrXZ
#HematologySymposia #DeceraClinicalEducation
A leader in CAR T–cell therapy ahead of #ASH2025.
Join our Hematology Symposia, register in-person or online: https://bit.ly/4nyUrXZ
#HematologySymposia #DeceraClinicalEducation
November 26, 2025 at 3:50 PM
🔥 Spotlight: Dr. Michael D. Jain
A leader in CAR T–cell therapy ahead of #ASH2025.
Join our Hematology Symposia, register in-person or online: https://bit.ly/4nyUrXZ
#HematologySymposia #DeceraClinicalEducation
A leader in CAR T–cell therapy ahead of #ASH2025.
Join our Hematology Symposia, register in-person or online: https://bit.ly/4nyUrXZ
#HematologySymposia #DeceraClinicalEducation
We’re now Decera Clinical Education (deh-SAIR-uh), formerly CCO. Our name has evolved, but our expert-led CME/CE and trusted medical education remain the same. Thank you for celebrating this next chapter with us! Learn more:
Learn more → deceraclinical.com/education/co...
Learn more → deceraclinical.com/education/co...
November 21, 2025 at 7:11 PM
We’re now Decera Clinical Education (deh-SAIR-uh), formerly CCO. Our name has evolved, but our expert-led CME/CE and trusted medical education remain the same. Thank you for celebrating this next chapter with us! Learn more:
Learn more → deceraclinical.com/education/co...
Learn more → deceraclinical.com/education/co...
This easy-to-use checklist helps patients and providers communicate openly about treatment options and next steps in care.
💬 Download the infographic to support confident, informed conversations: https://bit.ly/46EATeK
💬 Download the infographic to support confident, informed conversations: https://bit.ly/46EATeK
Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist
Infographic resource and checklist with a brief overview of relapsed/refractory diffuse large B-cell Lymphoma, with highlight information on treatment options, and sample question to ask the care team...
bit.ly
November 18, 2025 at 6:40 PM
This easy-to-use checklist helps patients and providers communicate openly about treatment options and next steps in care.
💬 Download the infographic to support confident, informed conversations: https://bit.ly/46EATeK
💬 Download the infographic to support confident, informed conversations: https://bit.ly/46EATeK
We have a few exciting events coming up this week!
View all our events here 👉 https://bit.ly/4468zjw
The best part? It’s not too late to register and join us!
For more events this year, click here: https://bit.ly/46gSR6U
View all our events here 👉 https://bit.ly/4468zjw
The best part? It’s not too late to register and join us!
For more events this year, click here: https://bit.ly/46gSR6U
November 17, 2025 at 4:51 PM
We have a few exciting events coming up this week!
View all our events here 👉 https://bit.ly/4468zjw
The best part? It’s not too late to register and join us!
For more events this year, click here: https://bit.ly/46gSR6U
View all our events here 👉 https://bit.ly/4468zjw
The best part? It’s not too late to register and join us!
For more events this year, click here: https://bit.ly/46gSR6U
Download this expert-curated slideset on extensive-stage small-cell lung cancer (ES-SCLC) to review current and emerging strategies for first-line treatment, including new clinical trial data on chemoimmunotherapy and optimizing maintenance therapy.
👉 Access the slides here: https://bit.ly/4owLHSF
👉 Access the slides here: https://bit.ly/4owLHSF
Extensive-Stage Small-Cell Lung Cancer With Recent Therapeutic Advancements for First-line Therapy
Download these slides on current and emerging treatment strategies for extensive-stage SCLC (ES-SCLC), with a focus on key highlights of recent clinical trial data to shed light on the role of chemoim...
bit.ly
November 15, 2025 at 8:51 PM
Download this expert-curated slideset on extensive-stage small-cell lung cancer (ES-SCLC) to review current and emerging strategies for first-line treatment, including new clinical trial data on chemoimmunotherapy and optimizing maintenance therapy.
👉 Access the slides here: https://bit.ly/4owLHSF
👉 Access the slides here: https://bit.ly/4owLHSF
Download this patient–provider communication checklist for key information on treatment for newly diagnosed HER2+ metastatic breast cancer and questions to guide conversations with your doctor about treatment decisions.
Download here: https://bit.ly/3WUYZMD
#HER2 #CME #MedicalEducation
Download here: https://bit.ly/3WUYZMD
#HER2 #CME #MedicalEducation
November 14, 2025 at 9:06 PM
Download this patient–provider communication checklist for key information on treatment for newly diagnosed HER2+ metastatic breast cancer and questions to guide conversations with your doctor about treatment decisions.
Download here: https://bit.ly/3WUYZMD
#HER2 #CME #MedicalEducation
Download here: https://bit.ly/3WUYZMD
#HER2 #CME #MedicalEducation
☕ Worry Free in HAE: Coffee Talks With the Experts! Explore the latest advances in long-term prophylaxis for hereditary angioedema (HAE) with this expert-curated downloadable slideset.
Download: https://bit.ly/3JudZho
#HereditaryAngioedema #HAE #Prophylaxis #MedicalEducation
Download: https://bit.ly/3JudZho
#HereditaryAngioedema #HAE #Prophylaxis #MedicalEducation
November 8, 2025 at 9:11 PM
☕ Worry Free in HAE: Coffee Talks With the Experts! Explore the latest advances in long-term prophylaxis for hereditary angioedema (HAE) with this expert-curated downloadable slideset.
Download: https://bit.ly/3JudZho
#HereditaryAngioedema #HAE #Prophylaxis #MedicalEducation
Download: https://bit.ly/3JudZho
#HereditaryAngioedema #HAE #Prophylaxis #MedicalEducation
✨ New Resource Available! ✨ This slideset highlights the importance of diagnosing heart failure early.
📑 Access the slides here: https://bit.ly/4qzc1Nr
#HeartFailure #PatientCare #MedicalEducation
📑 Access the slides here: https://bit.ly/4qzc1Nr
#HeartFailure #PatientCare #MedicalEducation
November 5, 2025 at 4:20 PM
✨ New Resource Available! ✨ This slideset highlights the importance of diagnosing heart failure early.
📑 Access the slides here: https://bit.ly/4qzc1Nr
#HeartFailure #PatientCare #MedicalEducation
📑 Access the slides here: https://bit.ly/4qzc1Nr
#HeartFailure #PatientCare #MedicalEducation
We have a few medical education events this week! See what events you can join this week!
✨👉 View events here: https://clinicaloptions.com/events?startdate=11/03/2025&enddate=11/09/2025
#CME #MedicalEducation
✨👉 View events here: https://clinicaloptions.com/events?startdate=11/03/2025&enddate=11/09/2025
#CME #MedicalEducation
November 3, 2025 at 2:11 PM
We have a few medical education events this week! See what events you can join this week!
✨👉 View events here: https://clinicaloptions.com/events?startdate=11/03/2025&enddate=11/09/2025
#CME #MedicalEducation
✨👉 View events here: https://clinicaloptions.com/events?startdate=11/03/2025&enddate=11/09/2025
#CME #MedicalEducation
BIG NEWS! CCO will soon be known by a new name! We’re evolving into Decera Clinical Education (deh-SAIR-uh).
Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.
Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.
October 30, 2025 at 7:08 PM
BIG NEWS! CCO will soon be known by a new name! We’re evolving into Decera Clinical Education (deh-SAIR-uh).
Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.
Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.
Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute to see why: https://bit.ly/3KRmxiM
#MedicalEducation
#MedicalEducation
October 29, 2025 at 5:15 PM
Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute to see why: https://bit.ly/3KRmxiM
#MedicalEducation
#MedicalEducation
Download the Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist 📄 Empower patients and providers to work together toward better care.
Access the checklist here: https://bit.ly/46EATeK
Access the checklist here: https://bit.ly/46EATeK
Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist
Infographic resource and checklist with a brief overview of relapsed/refractory diffuse large B-cell Lymphoma, with highlight information on treatment options, and sample question to ask the care team.
clinicaloptions.com
October 24, 2025 at 9:10 PM
Download the Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist 📄 Empower patients and providers to work together toward better care.
Access the checklist here: https://bit.ly/46EATeK
Access the checklist here: https://bit.ly/46EATeK
🩺 Words matter in patient care. Just as we say “patients have cancer” rather than “cancer patients,” the same approach should guide conversations around overweight and obesity.
Watch here: https://bit.ly/3KRmxiM
Watch here: https://bit.ly/3KRmxiM
October 23, 2025 at 3:53 PM
🩺 Words matter in patient care. Just as we say “patients have cancer” rather than “cancer patients,” the same approach should guide conversations around overweight and obesity.
Watch here: https://bit.ly/3KRmxiM
Watch here: https://bit.ly/3KRmxiM
✨ This slideset highlights how the latest advances in primary biliary cholangitis (PBC) are shifting the focus toward personalized care and symptom management.
📑 Access the slides here: https://bit.ly/4mVkp6T
#PBC #LiverDisease #PatientCare #MedicalEducation
📑 Access the slides here: https://bit.ly/4mVkp6T
#PBC #LiverDisease #PatientCare #MedicalEducation
Patient Perspectives on New Developments in PBC: Individualizing Patient Care
With these slides, learn how recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Discover how you can integrate patient ...
bit.ly
October 22, 2025 at 4:30 PM
✨ This slideset highlights how the latest advances in primary biliary cholangitis (PBC) are shifting the focus toward personalized care and symptom management.
📑 Access the slides here: https://bit.ly/4mVkp6T
#PBC #LiverDisease #PatientCare #MedicalEducation
📑 Access the slides here: https://bit.ly/4mVkp6T
#PBC #LiverDisease #PatientCare #MedicalEducation
Overcome the most common challenges when discussing vaccines with patients, parents, and caregivers.
Watch our new on-demand video: Experts in the Hot Seat! Powering Up Pediatric Vaccines Against Rising Resistance: https://bit.ly/3VTLWuo
#Vaccines #MedicalEducation
Watch our new on-demand video: Experts in the Hot Seat! Powering Up Pediatric Vaccines Against Rising Resistance: https://bit.ly/3VTLWuo
#Vaccines #MedicalEducation
October 16, 2025 at 4:11 PM
Overcome the most common challenges when discussing vaccines with patients, parents, and caregivers.
Watch our new on-demand video: Experts in the Hot Seat! Powering Up Pediatric Vaccines Against Rising Resistance: https://bit.ly/3VTLWuo
#Vaccines #MedicalEducation
Watch our new on-demand video: Experts in the Hot Seat! Powering Up Pediatric Vaccines Against Rising Resistance: https://bit.ly/3VTLWuo
#Vaccines #MedicalEducation
A Pocket Guide 💥💻 Nursing Management of Patients Receiving EGFR-Targeted Therapy for NSCLC! This quick reference resource helps nurses monitor and manage adverse events in patients receiving EGFR-targeted therapy.
👉 Download the PDF and keep it handy for everyday practice! https://bit.ly/481mElj
👉 Download the PDF and keep it handy for everyday practice! https://bit.ly/481mElj
Nursing Management of Patients Receiving EGFR-Targeted Therapy for NSCLC: A Pocket Guide
Download this pocket guide to help with the monitoring and management of adverse events associated with EGFR-targeted therapy for patients with NSCLC.
bit.ly
October 13, 2025 at 7:18 PM
A Pocket Guide 💥💻 Nursing Management of Patients Receiving EGFR-Targeted Therapy for NSCLC! This quick reference resource helps nurses monitor and manage adverse events in patients receiving EGFR-targeted therapy.
👉 Download the PDF and keep it handy for everyday practice! https://bit.ly/481mElj
👉 Download the PDF and keep it handy for everyday practice! https://bit.ly/481mElj
Reposted by Decera Clinical Education
New Education article on HPV positive oropharyngeal cancer.
How can doctors spot this easily missed condition?
Includes #BMJInfographics that illustrate key points #MedEd
www.bmj.com/content/391/...
How can doctors spot this easily missed condition?
Includes #BMJInfographics that illustrate key points #MedEd
www.bmj.com/content/391/...
October 13, 2025 at 10:40 AM
New Education article on HPV positive oropharyngeal cancer.
How can doctors spot this easily missed condition?
Includes #BMJInfographics that illustrate key points #MedEd
www.bmj.com/content/391/...
How can doctors spot this easily missed condition?
Includes #BMJInfographics that illustrate key points #MedEd
www.bmj.com/content/391/...
Reposted by Decera Clinical Education
What is the risk of stroke associated with risperidone use in persons living with dementia?
New study (N=28k risperidone, 136k control) from UK Clinical Practice Research Datalink found ⬆️risk, esp. in those w/ previous stroke.
Helpful for quantifying risk vs benefit of risperidone use.
#medsky
New study (N=28k risperidone, 136k control) from UK Clinical Practice Research Datalink found ⬆️risk, esp. in those w/ previous stroke.
Helpful for quantifying risk vs benefit of risperidone use.
#medsky
Risk of stroke associated with risperidone in dementia with and without co-morbid cardiovascular disease: population-based matched cohort study cambridge.org/core/journal...
#Alzheimers #dementia #stroke #geriatrics #neurology #cardiology
#Alzheimers #dementia #stroke #geriatrics #neurology #cardiology
October 13, 2025 at 12:00 PM
What is the risk of stroke associated with risperidone use in persons living with dementia?
New study (N=28k risperidone, 136k control) from UK Clinical Practice Research Datalink found ⬆️risk, esp. in those w/ previous stroke.
Helpful for quantifying risk vs benefit of risperidone use.
#medsky
New study (N=28k risperidone, 136k control) from UK Clinical Practice Research Datalink found ⬆️risk, esp. in those w/ previous stroke.
Helpful for quantifying risk vs benefit of risperidone use.
#medsky
🧠 Elucidating Multiple Sclerosis Treatment: Spotlight on Disease-Modifying Therapies
Build your expertise in MS care with a suite of on-demand resources designed for busy clinicians! 👉 https://bit.ly/3JQwEnq
Build your expertise in MS care with a suite of on-demand resources designed for busy clinicians! 👉 https://bit.ly/3JQwEnq
Elucidating Multiple Sclerosis Treatment: Spotlight on Disease-Modifying Therapies
Gain in-depth knowledge on evidence-based diagnostic criteria for multiple sclerosis and assessment of progression as well as strategies to increase patient adherence and characteristics to determine ...
bit.ly
October 9, 2025 at 4:00 PM
🧠 Elucidating Multiple Sclerosis Treatment: Spotlight on Disease-Modifying Therapies
Build your expertise in MS care with a suite of on-demand resources designed for busy clinicians! 👉 https://bit.ly/3JQwEnq
Build your expertise in MS care with a suite of on-demand resources designed for busy clinicians! 👉 https://bit.ly/3JQwEnq
Download this resource for your patients! Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC) 💥👉 Download here: https://bit.ly/3IFIpge #HER2 #MedEd #EdSky
Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC)
Downloadable PDF resource as a helpful guide for patients in understanding treatment options for HER2+ GEA and BTC.
bit.ly
October 4, 2025 at 8:52 PM
Download this resource for your patients! Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC) 💥👉 Download here: https://bit.ly/3IFIpge #HER2 #MedEd #EdSky
🧠💉The way we communicate matters. This practical, shareable guide equips HCPs with patient-friendly talking points to navigate meningitis vaccine discussions with confidence. Download: https://bit.ly/46sah0l
Making the Meningitis Conversation Count: Your Guide to Confident Meningitis Vaccine Discussions
Download this shareable guide to learn how your words can help proactively prevent meningitis infection. This handy how-to features patient-friendly talking points for HCPs to use when discussing the ...
bit.ly
September 28, 2025 at 7:58 PM
🧠💉The way we communicate matters. This practical, shareable guide equips HCPs with patient-friendly talking points to navigate meningitis vaccine discussions with confidence. Download: https://bit.ly/46sah0l
Overview of AATD: Liver vs Lung Disease
Approximately 50% of Americans with AATD, which is approximately 1 in every 3000 to 5000 people, may develop reduced lung function over time. In comparison, only approximately 10% of adults with AATD will go on to develop liver disease.
Approximately 50% of Americans with AATD, which is approximately 1 in every 3000 to 5000 people, may develop reduced lung function over time. In comparison, only approximately 10% of adults with AATD will go on to develop liver disease.
September 9, 2025 at 3:26 PM
Overview of AATD: Liver vs Lung Disease
Approximately 50% of Americans with AATD, which is approximately 1 in every 3000 to 5000 people, may develop reduced lung function over time. In comparison, only approximately 10% of adults with AATD will go on to develop liver disease.
Approximately 50% of Americans with AATD, which is approximately 1 in every 3000 to 5000 people, may develop reduced lung function over time. In comparison, only approximately 10% of adults with AATD will go on to develop liver disease.